WuXi Bio taps equity market for $795m
WuXi Biologics (Cayman) bagged HK$6.17bn ($795m) on Monday after boosting the size of a new equity issuance.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: